Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 8, 2010, Pages 783-792

  Arosio, Paolo ^a   Levi, Sonia ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Ferritin; Iron homeostasis; Mitochondria; Neurodegeneration; Oxidative damage

Indexed keywords

ACETYLCYSTEINE; DEFERASIROX; FERRITIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IRON; IRON CHELATING AGENT; LACTACYSTIN; REACTIVE OXYGEN METABOLITE;

ANEMIA; ANTIOXIDANT ACTIVITY; CELL PROTECTION; CELL STRESS; CYTOSOL; DOPAMINERGIC NERVE CELL; ENZYME REGULATION; FERRITINOPATHY; GENE MUTATION; GENETIC DISORDER; HEART FAILURE; HOMEOSTASIS; HUMAN; HYPERFERRITINEMIA; IRON DEPLETION; IRON KINETICS; IRON METABOLISM DISORDER; IRON STORAGE; ISCHEMIC PRECONDITIONING; KNOCKOUT MOUSE; MITOCHONDRION; NERVE DEGENERATION; NEUROFERRITINOPATHY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIDEROBLASTIC ANEMIA;

ANIMALS; CELLS; CYTOSOL; FERRITINS; HOMEOSTASIS; HUMANS; IRON; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE STRESS;

MUS;

EID: 77953810574     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.02.005     Document Type: Review

References (127)

1. Laufberger V. Sur la Cristallisation de la Ferritine. Bull. Soc. Chim. Biol. 1937, 19:1575-1582.
2. Chasteen N.D., Harrison P.M. Mineralization in ferritin: an efficient means of iron storage. J. Struct. Biol. 1999, 126:182-194.
3. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996, 1275:161-203.
4. Theil E.C. Ferritin: at the crossroads of iron and oxygen metabolism. J. Nutr. 2003, 133:1549S-1553S.
5. Arosio P., Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 2002, 33:457-463.
6. Carrondo M.A. Ferritins, iron uptake and storage from the bacterioferritin viewpoint. EMBO J. 2003, 22:1959-1968.
7. Levi S., Corsi B., Bosisio M., Invernizzi R., Volz A., Sanford D., Arosio P., Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem. 2001, 276:24437-24440.
8. Arosio P., Ingrassia R., Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim. Biophys. Acta 2009, 1790:589-599.
9. Levi S., Corsi B., Rovida E., Cozzi A., Santambrogio P., Albertini A., Arosio P. Construction of a ferroxidase center in human ferritin L-chain. J. Biol. Chem. 1994, 269:30334-30339.
10. Zhao G., Arosio P., Chasteen N.D. Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study. Biochemistry 2006, 45:3429-3436.
11. Santambrogio P., Levi S., Cozzi A., Rovida E., Albertini A., Arosio P. Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J. Biol. Chem. 1993, 268:12744-12748.
12. Shi H., Bencze K.Z., Stemmler T.L., Philpott C.C. A cytosolic iron chaperone that delivers iron to ferritin. Science 2008, 320:1207-1210.
13. Makeyev A.V., Liebhaber S.A. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 2002, 8:265-278.
14. Chasteen N.D. Ferritin. Uptake, storage, and release of iron. Met. Ions Biol. Syst. 1998, 35:479-514.
15. Cassanelli S., Moulis J. Sulfide is an efficient iron releasing agent for mammalian ferritins. Biochim. Biophys. Acta 2001, 1547:174-182.
16. Theil E.C., Matzapetakis M., Liu X. Ferritins: iron/oxygen biominerals in protein nanocages. J. Biol. Inorg. Chem. 2006, 11:803-810.
17. Jin W., Takagi H., Pancorbo B., Theil E.C. "Opening" the ferritin pore for iron release by mutation of conserved amino acids at interhelix and loop sites. Biochemistry 2001, 40:7525-7532.
18. Hasan M.R., Tosha T., Theil E.C. Ferritin contains less iron (59Fe) in cells when the protein pores are unfolded by mutation. J. Biol. Chem. 2008, 283:31394-31400.
19. Cozzi A., Rovelli E., Frizzale G., Campanella A., Amendola M., Arosio P., Levi S. Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy. Neurobiol. Dis. 2010, 37:77-85.
20. Cozzi A., Santambrogio P., Corsi B., Campanella A., Arosio P., Levi S. Characterization of the l-ferritin variant 460InsA responsible of a hereditary ferritinopathy disorder. Neurobiol. Dis. 2006, 23:644-652.
21. Liu Y., Hu N. Electrochemical detection of natural DNA damage induced by ferritin/ascorbic acid/H2O2 system and amplification of DNA damage by endonuclease Fpg. Biosens. Bioelectron. 2009, 25:185-190.
22. Kang J.H. Ferritin enhances salsolinol-mediated DNA strand breakage: protection by carnosine and related compounds. Toxicol. Lett. 2009, 188:20-25.
23. Rousseau I., Puntarulo S. Ferritin-dependent radical generation in rat liver homogenates. Toxicology 2009, 264:155-161.
24. Kaur D., Rajagopalan S., Chinta S., Kumar J., Di Monte D., Cherny R.A., Andersen J.K. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res. 2007, 1140:188-194.
25. Kaur D., Rajagopalan S., Andersen J.K. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease. Brain Res. 2009, 1297:17-22.
26. Mehlhase J., Sandig G., Pantopoulos K., Grune T. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. Free Radic. Biol. Med. 2005, 38:276-285.
27. De Domenico I., Vaughn M.B., Li L., Bagley D., Musci G., Ward D.M., Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 2006, 25:5396-5404.
28. De Domenico I., Ward D.M., Kaplan J. Specific iron chelators determine the route of ferritin degradation. Blood 2009, 114:4546-4551.
29. Kwok J.C., Richardson D.R. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol. Pharmacol. 2004, 65:181-195.
30. Truty J., Malpe R., Linder M.C. Iron prevents ferritin turnover in hepatic cells. J. Biol. Chem. 2001, 276:48775-48780.
31. Hentze M.W., Rouault T.A., Harford J.B., Klausner R.D. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 1989, 244:357-359.
32. Walden W.E., Selezneva A.I., Dupuy J., Volbeda A., Fontecilla-Camps J.C., Theil E.C., Volz K. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science 2006, 314:1903-1908.
33. Tong W.H., Rouault T.A. Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals 2007, 20:549-564.
34. Eisenstein R.S., Tuazon P.T., Schalinske K.L., Anderson S.A., Traugh J.A. Iron-responsive element-binding protein. Phosphorylation by protein kinase C. J. Biol. Chem. 1993, 268:27363-27370.
35. Wang J., Fillebeen C., Chen G., Biederbick A., Lill R., Pantopoulos K. Iron-dependent degradation of apo-IRP1 by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 2007, 27:2423-2430.
36. Ishikawa H., Kato M., Hori H., Ishimori K., Kirisako T., Tokunaga F., Iwai K. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol. Cell 2005, 19:171-181.
37. Toth I., Yuan L., Rogers J.T., Boyce H., Bridges K.R. Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J. Biol. Chem. 1999, 274:4467-4473.
38. Meyron-Holtz E.G., Ghosh M.C., Iwai K., LaVaute T., Brazzolotto X., Berger U.V., Land W., Ollivierre-Wilson H., Grinberg A., Love P., Rouault T.A. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004, 23:386-395.
39. Galy B., Ferring D., Minana B., Bell O., Janser H.G., Muckenthaler M., Schumann K., Hentze M.W. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 2005, 106:2580-2589.
40. Sammarco M.C., Ditch S., Banerjee A., Grabczyk E. Ferritin L and H subunits are differentially regulated on a post-transcriptional level. J. Biol. Chem. 2008, 283:4578-4587.
41. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
42. Hintze K.J., Theil E.C. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15048-15052.
43. Iwasaki K., Mackenzie E.L., Hailemariam K., Sakamoto K., Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol. Cell. Biol. 2006, 26:2845-2856.
44. Tsuji Y. JunD activates transcription of the human ferritin H gene through an antioxidant response element during oxidative stress. Oncogene 2005, 24:7567-7578.
45. Hintze K.J., Katoh Y., Igarashi K., Theil E.C. Bach1 repression of ferritin and thioredoxin reductase1 is heme-sensitive in cells and in vitro and coordinates expression with heme oxygenase1, beta-globin, and NADP(H) quinone (oxido) reductase1. J. Biol. Chem. 2007, 282:34365-34371.
46. Hintze K.J., Theil E.C. Cellular regulation and molecular interactions of the ferritins. Cell. Mol. Life Sci. 2006, 63:591-600.
47. Balla G., Jacob H.S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J.W., Vercellotti G.M. Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 1992, 267:18148-18153.
48. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., Torti F.M., Torti S.V., Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529-542.
49. Ikegami Y., Inukai K., Imai K., Sakamoto Y., Katagiri H., Kurihara S., Awata T., Katayama S. Adiponectin upregulates ferritin heavy chain in skeletal muscle cells. Diabetes 2009, 58:61-70.
50. Sengupta R., Burbassi S., Shimizu S., Cappello S., Vallee R.B., Rubin J.B., Meucci O. Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J. Neurosci. 2009, 29:2534-2544.
51. Mackenzie E.L., Ray P.D., Tsuji Y. Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress. Free Radic. Biol. Med. 2008, 44:1762-1771.
52. Zhang K.H., Tian H.Y., Gao X., Lei W.W., Hu Y., Wang D.M., Pan X.C., Yu M.L., Xu G.J., Zhao F.K., Song J.G. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res. 2009, 69:5340-5348.
53. Zhang F., Wang W., Tsuji Y., Torti S.V., Torti F.M. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J. Biol. Chem. 2008, 283:33911-33918.
54. Faniello M.C., Di Sanzo M., Quaresima B., Baudi F., Di Caro V., Cuda G., Morrone G., Del Sal G., Spinelli G., Venuta S., Costanzo F. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y. Int. J. Biochem. Cell Biol. 2008, 40:2110-2119.
55. Bulvik B., Grinberg L., Eliashar R., Berenshtein E., Chevion M.M. Iron, ferritin and proteins of the methionine-centered redox cycle in young and old rat hearts. Mech. Ageing Dev. 2009, 130:139-144.
56. Fan Y., Yamada T., Shimizu T., Nanashima N., Akita M., Suto K., Tsuchida S. Ferritin expression in rat hepatocytes and Kupffer cells after lead nitrate treatment. Toxicol. Pathol. 2009, 37:209-217.
57. Omiya S., Hikoso S., Imanishi Y., Saito A., Yamaguchi O., Takeda T., Mizote I., Oka T., Taneike M., Nakano Y., Matsumura Y., Nishida K., Sawa Y., Hori M., Otsu K. Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes. J. Mol. Cell. Cardiol. 2009, 46:59-66.
58. Robello E., Galatro A., Puntarulo S. Labile iron pool and ferritin content in developing rat brain gamma-irradiated in utero. Neurotoxicology 2009, 30:430-435.
59. Cozzi A., Corsi B., Levi S., Santambrogio P., Albertini A., Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J. Biol. Chem. 2000, 275:25122-25129.
60. Epsztejn S., Glickstein H., Picard V., Slotki I.N., Breuer W., Beaumont C., Cabantchik Z.I. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 1999, 94:3593-3603.
61. Cozzi A., Corsi B., Levi S., Santambrogio P., Biasiotto G., Arosio P. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin. Blood 2004, 103:2377-2383.
62. Ferreira C., Bucchini D., Martin M.E., Levi S., Arosio P., Grandchamp B., Beaumont C. Early embryonic lethality of H ferritin gene deletion in mice. J. Biol. Chem. 2000, 275:3021-3024.
63. Darshan D., Vanoaica L., Richman L., Beermann F., Kuhn L.C. Conditional deletion of ferritin H in mice induces loss of iron storage and liver damage. Hepatology 2009, 50:852-860.
64. Chevion M., Leibowitz S., Aye N.N., Novogrodsky O., Singer A., Avizemer O., Bulvik B., Konijn A.M., Berenshtein E. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin. J. Mol. Cell. Cardiol. 2008, 45:839-845.
65. Obolensky A., Berenshtein E., Konijn A.M., Banin E., Chevion M. Ischemic preconditioning of the rat retina: protective role of ferritin. Free Radic. Biol. Med. 2008, 44:1286-1294.
66. Zhu W., Xie W., Pan T., Xu P., Fridkin M., Zheng H., Jankovic J., Youdim M.B., Le W. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J. 2007, 21:3835-3844.
67. Kinderlerer A.R., Pombo Gregoire I., Hamdulay S.S., Ali F., Steinberg R., Silva G., Ali N., Wang B., Haskard D.O., Soares M.P., Mason J.C. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 2009, 113:1598-1607.
68. Zarjou A., Jeney V., Arosio P., Poli M., Antal-Szalmas P., Agarwal A., Balla G., Balla J. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J. Am. Soc. Nephrol. 2009, 20:1254-1263.
69. Zarjou A., Jeney V., Arosio P., Poli M., Zavaczki E., Balla G., Balla J. Ferritin-ferroxidase activity: a potent inhibitor of osteogenesis. J. Bone Miner. Res. 2009, Oct 12. [Epub ahead of print].
70. Kato J., Fujikawa K., Kanda M., Fukuda N., Sasaki K., Takayama T., Kobune M., Takada K., Takimoto R., Hamada H., Ikeda T., Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am. J. Hum. Genet. 2001, 69:191-197.
71. Cremonesi L., Foglieni B., Fermo I., Cozzi A., Paroni R., Ruggeri G., Belloli S., Levi S., Fargion S., Ferrari M., Arosio P. Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematologica 2003, 88:1110-1116.
72. Beaumont C., Leneuve P., Devaux I., Scoazec J.Y., Berthier M., Loiseau M.N., Grandchamp B., Bonneau D. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat. Genet. 1995, 11:444-446.
73. Girelli D., Corrocher R., Bisceglia L., Olivieri O., De Franceschi L., Zelante L., Gasparini P. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 1995, 86:4050-4053.
74. Burdon K.P., Sharma S., Chen C.S., Dimasi D.P., Mackey D.A., Craig J.E. A novel deletion in the FTL gene causes hereditary hyperferritinemia cataract syndrome (HHCS) by alteration of the transcription start site. Hum. Mutat. 2007, 28:742.
75. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. Best Pract. Res. Clin. Haematol. 2005, 18:251-263.
76. Messa E., Pellegrino R.M., Palmieri A., Carturan S., Cilloni D., Saglio G., Roetto A. Identification of a novel mutation in the L ferritin iron-responsive element causing hereditary hyperferritinemia-cataract syndrome. Acta Haematol. 2009, 122:223-225.
77. Goralska M., Holley B.L., McGahan M.C. Overexpression of H- and L-ferritin subunits in lens epithelial cells: Fe metabolism and cellular response to UVB irradiation. Invest. Ophthalmol. Vis. Sci. 2001, 42:1721-1727.
78. Mumford A.D., Cree I.A., Arnold J.D., Hagan M.C., Rixon K.C., Harding J.J. The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin. Br. J. Ophthalmol. 2000, 84:697-700.
79. Kannengiesser C., Jouanolle A.M., Hetet G., Mosser A., Muzeau F., Henry D., Bardou-Jacquet E., Mornet M., Brissot P., Deugnier Y., Grandchamp B., Beaumont C. A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica 2009, 94:335-339.
80. Foglieni B., Ferrari F., Goldwurm S., Santambrogio P., Castiglioni E., Sessa M., Antonietta Volonte M., Lalli S., Galli C., Wang X.S., Connor J., Sironi F., Canesi M., Biasiotto G., Pezzoli G., Levi S., Ferrari M., Arosio P., Cremonesi L. Analysis of ferritin genes in Parkinson disease. Clin. Chem. Lab. Med. 2007, 45:1450-1456.
81. Cremonesi L., Cozzi A., Girelli D., Ferrari F., Fermo I., Foglieni B., Levi S., Bozzini C., Camparini M., Ferrari M., Arosio P. Case report: a subject with a mutation in the ATG start codon of L-ferritin has no haematological or neurological symptoms. J. Med. Genet. 2004, 41:e81.
82. Levi S., Cozzi A., Arosio P. Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. Best Pract. Res. Clin. Haematol. 2005, 18:265-276.
83. Gregory A., Hayflick S.J. Neurodegeneration with brain iron accumulation. Folia Neuropathol. 2005, 43:286-296.
84. Burn J., Chinnery P.F. Neuroferritinopathy. Semin. Pediatr. Neurol. 2006, 13:176-181.
85. Curtis A.R., Fey C., Morris C.M., Bindoff L.A., Ince P.G., Chinnery P.F., Coulthard A., Jackson M.J., Jackson A.P., McHale D.P., Hay D., Barker W.A., Markham A.F., Bates D., Curtis A., Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 2001, 28:350-354.
86. Vidal R., Delisle M.B., Rascol O., Ghetti B. Hereditary ferritinopathy. J. Neurol. Sci. 2003, 207:110-111.
87. Mancuso M., Davidzon G., Kurlan R.M., Tawil R., Bonilla E., Di Mauro S., Powers J.M. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J. Neuropathol. Exp. Neurol. 2005, 64:280-294.
88. Ohta E., Nagasaka T., Shindo K., Toma S., Nagasaka K., Ohta K., Shiozawa Z. Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology 2008, 70:1493-1494.
89. Kubota A., Hida A., Ichikawa Y., Momose Y., Goto J., Igeta Y., Hashida H., Yoshida K., Ikeda S., Kanazawa I., Tsuji S. A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Mov. Disord. 2009, 24:441-445.
90. Devos D., Tchofo P.J., Vuillaume I., Destee A., Batey S., Burn J., Chinnery P.F. Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain 2009, 132:e109.
91. Maciel P., Cruz V.T., Constante M., Iniesta I., Costa M.C., Gallati S., Sousa N., Sequeiros J., Coutinho P., Santos M.M. Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology 2005, 65:603-605.
92. Crompton D.E., Chinnery P.F., Bates D., Walls T.J., Jackson M.J., Curtis A.J., Burn J. Spectrum of movement disorders in neuroferritinopathy. Mov. Disord. 2005, 20:95-99.
93. Wills A.J., Sawle G.V., Guilbert P.R., Curtis A.R. Palatal tremor and cognitive decline in neuroferritinopathy. J. Neurol. Neurosurg. Psychiatry 2002, 73:91-92.
94. Crompton D.E., Chinnery P.F., Fey C., Curtis A.R., Morris C.M., Kierstan J., Burt A., Young F., Coulthard A., Curtis A., Ince P.G., Bates D., Jackson M.J., Burn J. Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood Cells Mol. Dis. 2002, 29:522-531.
95. Chinnery P.F., Crompton D.E., Birchall D., Jackson M.J., Coulthard A., Lombes A., Quinn N., Wills A., Fletcher N., Mottershead J.P., Cooper P., Kellett M., Bates D., Burn J. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007, 130:110-119.
96. Vidal R., Miravalle L., Gao X., Barbeito A.G., Baraibar M.A., Hekmatyar S.K., Widel M., Bansal N., Delisle M.B., Ghetti B. Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J. Neurosci. 2008, 28:60-67.
97. Barbeito A.G., Garringer H.J., Baraibar M.A., Gao X., Arredondo M., Nunez M.T., Smith M.A., Ghetti B., Vidal R. Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J. Neurochem. 2009, 109:1067-1078.
98. Baraibar M.A., Barbeito A.G., Muhoberac B.B., Vidal R. Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration. J. Biol. Chem. 2008, 283:31679-31689.
99. Zancani M., Peresson C., Biroccio A., Federici G., Urbani A., Murgia I., Soave C., Micali F., Vianello A., Macri F. Evidence for the presence of ferritin in plant mitochondria. Eur. J. Biochem. 2004, 271:3657-3664.
100. Missirlis F., Holmberg S., Georgieva T., Dunkov B.C., Rouault T.A., Law J.H. Characterization of mitochondrial ferritin in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5893-5898.
101. Drysdale J., Arosio P., Invernizzi R., Cazzola M., Volz A., Corsi B., Biasiotto G., Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol. Dis. 2002, 29:376-383.
102. Levi S., Arosio P. Mitochondrial ferritin. Int. J. Biochem. Cell Biol. 2004, 36:1887-1889.
103. Cazzola M., Invernizzi R., Bergamaschi G., Levi S., Corsi B., Travaglino E., Rolandi V., Biasiotto G., Drysdale J., Arosio P. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003, 101:1996-2000.
104. Santambrogio P., Biasiotto G., Sanvito F., Olivieri S., Arosio P., Levi S. Mitochondrial ferritin expression in adult mouse tissues. J. Histochem. Cytochem. 2007, 55:1129-1137.
105. Langlois d'Estaintot B., Santambrogio P., Granier T., Gallois B., Chevalier J.M., Precigoux G., Levi S., Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J. Mol. Biol. 2004, 340:277-293.
106. Bou-Abdallah F., Santambrogio P., Levi S., Arosio P., Chasteen N.D. Unique iron binding and oxidation properties of human mitochondrial ferritin: a comparative analysis with Human H-chain ferritin. J. Mol. Biol. 2005, 347:543-554.
107. Corsi B., Cozzi A., Arosio P., Drysdale J., Santambrogio P., Campanella A., Biasiotto G., Albertini A., Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J. Biol. Chem. 2002, 277:22430-22437.
108. Nie G., Sheftel A.D., Kim S.F., Ponka P. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 2005, 105:2161-2167.
109. Nie G., Chen G., Sheftel A.D., Pantopoulos K., Ponka P. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. Blood 2006, 108:2428-2434.
110. Snyder A.M., Wang X., Patton S.M., Arosio P., Levi S., Earley C.J., Allen R.P., Connor J.R. Mitochondrial ferritin in the substantia nigra in restless legs syndrome. J. Neuropathol. Exp. Neurol. 2009, 68:1193-1199.
111. Campanella A., Rovelli E., Santambrogio P., Cozzi A., Taroni F., Levi S. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Hum. Mol. Genet. 2009, 18:1-11.
112. Campanella A., Isaya G., O'Neill H.A., Santambrogio P., Cozzi A., Arosio P., Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum. Mol. Genet. 2004, 13:2279-2288.
113. Lu Z., Nie G., Li Y., Soe-Lin S., Tao Y., Cao Y., Zhang Z., Liu N., Ponka P., Zhao B. Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism. Antioxid. Redox Signal. 2009, 11:1791-1803.
114. Bulteau A.L., Lundberg K.C., Ikeda-Saito M., Isaya G., Szweda L.I. Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5987-5991.
115. Lill R., Muhlenhoff U. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 2008, 77:669-700.
116. Zanella I., Derosas M., Corrado M., Cocco E., Cavadini P., Biasiotto G., Poli M., Verardi R., Arosio P. The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochim. Biophys. Acta 2008, 1782:90-98.
117. Huang M.L., Becker E.M., Whitnall M., Rahmanto Y.S., Ponka P., Richardson D.R. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16381-16386.
118. Whitnall M., Rahmanto Y.S., Sutak R., Xu X., Becker E.M., Mikhael M.R., Ponka P., Richardson D.R. The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9757-9762.
119. Popescu B.F., Pickering I.J., George G.N., Nichol H. The chemical form of mitochondrial iron in Friedreich's ataxia. J. Inorg. Biochem. 2007, 101:957-966.
120. Michael S., Petrocine S.V., Qian J., Lamarche J.B., Knutson M.D., Garrick M.D., Koeppen A.H. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia. Cerebellum 2006, 5:257-267.
121. Koeppen A.H., Michael S.C., Knutson M.D., Haile D.J., Qian J., Levi S., Santambrogio P., Garrick M.D., Lamarche J.B. The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol. 2007, 114:163-173.
122. Alcindor T., Bridges K.R. Sideroblastic anaemias. Br. J. Haematol. 2002, 116:733-743.
123. Della Porta M.G., Malcovati L., Invernizzi R., Travaglino E., Pascutto C., Maffioli M., Galli A., Boggi S., Pietra D., Vanelli L., Marseglia C., Levi S., Arosio P., Lazzarino M., Cazzola M. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006, 20:549-555.
124. Tehranchi R., Fadeel B., Forsblom A.M., Christensson B., Samuelsson J., Zhivotovsky B., Hellstrom-Lindberg E. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood 2003, 101:1080-1086.
125. Allikmets R., Raskind W.H., Hutchinson A., Schueck N.D., Dean M., Koeller D.M. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum. Mol. Genet. 1999, 8:743-749.
126. Cavadini P., Biasiotto G., Poli M., Levi S., Verardi R., Zanella I., Derosas M., Ingrassia R., Corrado M., Arosio P. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007, 109:3552-3559.
127. Shen L., Kondo Y., Ahmed S., Boumber Y., Konishi K., Guo Y., Chen X., Vilaythong J.N., Issa J.P. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel. Cancer Res. 2007, 67:11335-11343.